Researchers have been battling to find the cure for cancer since we began to understand what cancer really was. A cure is the ultimate goal, but most medical professionals and patients would be ecstatic even hearing about new treatments. Current cancer treatments often come rife with side effects so severe that many choose to forgo them altogether. Stopping the growth of malicious cancer cells is the main goal of treatment, and removing them altogether is even better. The problem is, this kind of treatment almost always causes damage to surrounding healthy cells.
A treatment that changes cancerous cells into healthy, supportive cells sounds ideal. Transforming malignant cells into antibodies that would attack remaining cancer cells sounds too good to be true. Thanks to a groundbreaking study by scientists at The Scripps Research Institute (TSRI), this new, powerful form of cancer therapy could really be on the horizon.
An Accidental Discovery
The laboratory team was working on therapies for certain immune cell or blood factor deficiencies when they noticed some unusual effects of antibodies on marrow cells. They had been searching for antibodies that activate growth-factor receptors on immature bone marrow cells, meaning the antibodies would be able to induce these cells to mature into specific blood cell types.
After successfully identifying a number of antibodies that activated the bone marrow cell-receptors this way, the researchers noticed that some of the antibodies were having unexpected effects on the cells. Some of them were maturing into cells that were radically different from what had been expected, such as neural cells. This got the team thinking, could this method be used to convert cancerous marrow cells (leukemia cells) into non-cancerous cells?
Transformation
In the new study, Richard A. Lerner, institute professor and the Lita Annenberg Hazen professor of Immunochemistry at TSRI and senior investigator, teamed up with colleagues, including first author Kyungmoo Yea, an assistant professor of cellular and molecular biology at TSRI. They decided to test 20 of the recently discovered receptor-activating antibodies on acute myeloid leukemia cells taken from human patients. One of the antibodies ended up having an incredible impact on the leukemia cells.
Most acute myeloid leukemia cells have the thrombopoietin (TPO) receptor, a receptor the winning antibody selectively and potently activated in marrow cells. When the antibody was applied to healthy marrow cells, the cells matured into blood-platelet-producing cells (megakaryocytes). When applied to the acute myeloid leukemia cells, though, the antibody caused them to mature into dendritic cells, which are key support cells in the body’s immune system.
This alone would have been a success — the researchers had effectively transformed cancerous cells into non-cancerous, helpful immune system cells. The team pushed further, though, and found that with longer exposures to the antibodies and other regulated conditions, the dendritic cells matured even more. The final product was a group of cells that very closely resembled natural killer (NK) cells. One of the body’s rapid immune defenses, NK cells are capable of rapidly attacking potentially dangerous pathogens and tumors even if they don’t contain the biomarkers normally identified by other immune cells.
“That antibody could have turned those acute myeloid leukemia cells into a lot of other cell types, but somehow we were lucky enough to get NK cells,” Lerner said in a press release.
‘Fratricide’
These induced NK cells possessed a few unique characteristics, observed by the team through electron microscopy. The cells possessed extending tendrils that had made their way through the outer membranes of closeby leukemia cells — the kind of cells they would still be, had they not been exposed to the antibody. In lab tests, the NK cells betrayed their former brethren at an impressive pace: a “modest” number of NK cells took out about 15 percent of the surrounding leukemic cell population in only 24 hours.
An interesting detail noted by the researchers is the purely fratricidal nature of the NK cells. They attacked only related leukemia cells, while unrelated breast cancer cells did not die off in large numbers when put into contact with the NK cells. The team is still unclear on why exactly the NK cells behave this way, but hypothesize that other, yet-to-be-discovered antibodies could be the key to turning other cancerous cell types into NK cells.
Lerner has named this type of therapy “fratricidins,” and pointed out that they would have several advantages. The antibodies would be clinically useful with little to no modification, and the high specificity of the NK cells would reduce the likelihood of damage to surrounding healthy cells. This would make fratricidins a possible treatment with much more tolerable effects than traditional treatments like chemotherapy.
On top of that, every cancer cell in a population is potentially convertible, so in a successful therapy the cancer-cell population might not just be reduced, but eliminated entirely.
Read more: Cancer Treatment Breakthrough: Researchers Engineer A Way To Make Leukemia Cells Kill Each Other
The Latest on: Cancer Treatment Breakthrough
[google_news title=”” keyword=”Cancer Treatment Breakthrough” num_posts=”10″ blurb_length=”0″ show_thumb=”left”]
via Google News
The Latest on: Cancer Treatment Breakthrough
- Bowel cancer: Scottish scientists make breakthrough on cancer discovery and treatmenton March 18, 2024 at 12:46 am
Dr Catherine Elliott, director of research at Cancer Research UK, said: “These findings by the team at the Cancer Research UK Scotland Institute and University of Glasgow offer an exciting opportunity ...
- New 3D scan could help monitor and diagnose bowel canceron March 17, 2024 at 5:18 pm
Positron Emission Tomography (PET) imaging can allow the entire bowel to be examined and for tumours to be studied while inside the body ...
- This Brain Cancer Breakthrough Should Excite Youon March 16, 2024 at 5:00 am
A flurry of new studies suggest scientists are finally figuring out how to harness the immune system to attack a ruthless form of brain cancer. While preliminary, the results offer hope that progress ...
- Cancer Breakthrough Therapy Makes Brain Tumour Disappear In Five Dayson March 15, 2024 at 8:47 pm
A 57-year-old woman witnessed her brain tumour almost vanish in five days with the help of a revolutionary treatment that bolsters the body’s immune system, with CAR-T therapy. Glioblastomas are ...
- BREAKTHROUGH: One blood test could detect multiple cancerson March 15, 2024 at 1:30 pm
It may sound like science fiction or a mean scam, but a new report goes on the record saying that we have reached the point where a simple blood test could ...
- Breakthrough cancer treatment nearly wipes out tumors in dayson March 13, 2024 at 2:01 pm
Clinical trials of patients with aggressive cancer have “revolutionized” the way scientists think about treating patients. The post Breakthrough cancer treatment nearly wipes out tumors in days ...
- AI Breakthrough in Lung Cancer Predictionon March 11, 2024 at 11:59 pm
AI, led by Washington University, shows promise in predicting brain metastasis in early-stage lung cancer, outperforming pathologists with 87% accuracy compared to 57.3%. The study suggests AI could ...
- Brain tumour patient had nine months to live - but breakthrough cancer treatment saved his lifeon March 9, 2024 at 1:19 pm
A man who was given months to live says his brain tumour has effectively vanished after he signed up for a world-first treatment - with doctors hailing a cure "could be on the horizon" ...
- ‘Significant cancer breakthrough’ as tiny needle ‘500 times thinner than human hair’ paves way for miracle cureon March 7, 2024 at 8:50 am
This allowed scientists to observe how cells react to treatment ... Professor of Brain Cancer Biology in Leeds' School of Medicine, called the findings "a significant breakthrough".
- 'Significant' surgery breakthrough could be cancer treatment game-changer, say expertson March 6, 2024 at 1:53 pm
A new device using "nanopipettes" give researchers the ability single tumour cells throughout duration of cancer treatment. According to experts, it is a "significant" breakthrough that may help in tr ...
via Bing News